Dongguan Mopeipei E-commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Dongguan Mopeipei E-commerce Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include PLANROME and PLUCLIKE. The owner is based in Dongguan Guangdong.

Room 102, No. 190

Taisha Road, Humen Town

Dongguan Guangdong 523899 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PLUCLIKE
PLUCLIKE
Registered 2025
PLANROME
PLANROME
Registered 2025

Trademark Classifications

Dongguan Mopeipei E-commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Dongguan Mopeipei E-commerce Co., Ltd. have?

Dongguan Mopeipei E-commerce Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Dongguan Mopeipei E-commerce Co., Ltd. file in?

Dongguan Mopeipei E-commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Dongguan Mopeipei E-commerce Co., Ltd.'s most well-known trademarks?

Dongguan Mopeipei E-commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as PLANROME and PLUCLIKE. These are among 2 currently registered trademarks in the portfolio.

What is Dongguan Mopeipei E-commerce Co., Ltd.'s trademark registration success rate?

Dongguan Mopeipei E-commerce Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.